Name
OÜ GPE GLOBALPHARMA
Registry code
12306448
VAT number
EE101579867
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
26.06.2012 (12)
Financial year
01.01-31.12
Capital
2 941.00 €
Activity
82921 - Packaging activities
84 232 €
5 718 €
7%
1 099 €
(estimate is approximate)
-1 453 €
2
Submitted
No tax arrears
-394%
111%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Sulepea ja Tint OÜ 12521566 | 5% - 147.00 EUR | - | - | |
| Global HR Partner OÜ 11808343 | 5% - 147.00 EUR | - | - | |
| Jaanus Pikani 29.12.1959 (64) | - | Board member | Direct ownership | |
| Ülo Isberg 28.10.1952 (71) | - | Board member | Direct ownership | |
| Andrus Tasa 10.01.1966 (58) | - | - | - | Founder |
| 2019 25.06.2020 | 2020 04.05.2021 | 2021 06.05.2022 | 2022 27.02.2023 | 2023 29.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 61 275 € | 77 549 € | 114 836 € | 85 565 € | 84 232 € |
| Net profit (loss) for the period | 28 780 € | -20 747 € | 8 649 € | -22 575 € | 5 718 € |
| Profit Margin | 47% | -27% | 8% | -26% | 7% |
| Current Assets | 30 606 € | 7 701 € | 8 482 € | 8 834 € | 4 305 € |
| Fixed Assets | 62 265 € | 0 € | 0 € | 1 079 € | 851 € |
| Total Assets | 92 871 € | 7 701 € | 8 482 € | 9 913 € | 5 156 € |
| Current Liabilities | 198 912 € | 35 727 € | 7 968 € | 12 084 € | 6 609 € |
| Non Current Liabilities | 0 € | 98 762 € | 118 653 € | 138 543 € | 0 € |
| Total Liabilities | - | 134 489 € | 126 621 € | 150 627 € | - |
| Share Capital | - | - | - | - | - |
| Equity | -106 041 € | -126 788 € | -118 139 € | -140 714 € | -1 453 € |
| Employees | 5 | 2 | 2 | 2 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 19 374.44 € | 4 571.81 € | 3 708.21 € | 3 |
| 2023 Q4 | 25 956.46 € | 6 095.47 € | 3 533.12 € | 3 |
| 2023 Q3 | 18 095.77 € | 6 122.72 € | 3 814.22 € | 3 |
| 2023 Q2 | 19 837.5 € | 4 666.65 € | 3 322.8 € | 3 |
| 2023 Q1 | 23 613.55 € | 5 257.72 € | 3 374.51 € | 5 |
| 2022 Q4 | 18 654.52 € | 4 248.06 € | 3 062.62 € | 5 |
| 2022 Q3 | 21 138.99 € | 6 127.58 € | 3 699.35 € | 5 |
| 2022 Q2 | 22 562.12 € | 5 271.21 € | 3 282.51 € | 5 |
| 2022 Q1 | 25 187.03 € | 4 281.06 € | 2 750.64 € | 5 |
| 2021 Q4 | 31 405.87 € | 6 541.99 € | 2 422.06 € | 5 |
| 2021 Q3 | 24 783.69 € | 8 615.86 € | 3 825.88 € | 6 |
| 2021 Q2 | 26 301.73 € | 13 557.08 € | 11 852.01 € | 6 |
| 2021 Q1 | 32 201.59 € | 14 793.98 € | 11 476.83 € | 6 |
| 2020 Q4 | 31 688.81 € | 12 822.32 € | 11 530.09 € | 6 |
| 2020 Q3 | 18 733.65 € | 12 188.6 € | 9 463.87 € | 6 |
| 2020 Q2 | 18 503.59 € | 12 268.91 € | 9 292.8 € | 5 |
| 2020 Q1 | 5 101.62 € | 9 084.1 € | 9 797.19 € | 5 |
